Inverse imaging of electrical activity of a heart muscle
A method for providing a representation of the distribution, fluctuation and/or movement of electrical activity through heart tissue, said method comprising: obtaining an ECG of the heart comprising said tissue; obtaining a model of the heart geometry; obtaining a model of the torso geometry; relating the measurements per electrode of the ECG to the heart and torso geometry and estimating the distribution, fluctuation and/or movement of electrical activity through heart tissue based upon a fastest route algorithm, shortest path algorithm and/or fast marching algorithm.
1. A method for providing a representation of the distribution, fluctuation and/or movement of electrical activity through heart tissue, said method comprising:
obtaining an ECG of the heart comprising said tissue;
obtaining a model of the heart geometry;
obtaining a model of the torso geometry;
relating the measurements per electrode of the ECG to the heart and torso geometry and estimating the distribution, fluctuation and/or movement of electrical activity through heart tissue based upon an electrical heat source model wherein an initial estimate of activation is based upon a fastest route algorithm, shortest path algorithm and/or fast marching algorithm.
2. The method according to claim 1 , whereby the representation is an estimation of the activation of different areas of the heart.
3. The method according to claim 1 , whereby the heart- and/or the torso geometry is based upon a measurement by MRI.
4. The method according to claim 1 , whereby repolarisation (recovery) of areas of the heart muscle is estimated based upon the sequence of activation through the heart.
5. The method according to claim 4 , further comprising adjusting the activation estimation by estimating the fiber orientation in at least one area of the heart muscle.
6. The method according to claim 4 , further comprising adjusting the recovery estimation by estimating the fiber orientation in at least one area of the heart muscle.
7. The method according to claim 4 , whereby the speed, activation or recovery estimation is optimised by a Levenberg-Marquardt method.
8. The method according to claim 1 , wherein an equivalent double layer model is used as an electrical source model.
9. The method according to claim 1 , wherein the amplitude of a local transmembrane potential in a heart muscle is estimated based on the ST segment of an ECG of said heart muscle.
10. The method according to claim 1 , wherein a volume conductor model of the heart and/or torso geometry is adjusted based upon a database of various heart and/or torso geometries.
11. The method according to claim 1 , wherein a source model of the heart is adjusted based upon a database of various heart geometries.
12. The method according to claim 1 , wherein the initial estimate of activation includes a multi-foci search for identifying an activation sequence.
13. A method for determining the effects of a substance on at least one area of a heart muscle, comprising
obtaining a first and at least one further representation of a heart muscle by performing steps further comprising
obtaining an ECG of the heart comprising said tissue,
obtaining a model of the heart geometry,
obtaining a model of the torso geometry, and
relating the measurements per electrode of the ECG to the heart and torso geometry and estimating the distribution, fluctuation and/or movement of electrical activity through heart tissue based upon an electrical heart source model wherein an initial estimate of activation is based upon a fastest route algorithm, shortest path algorithm and/or fast marching algorithm;
whereby said first representation is obtained from a heart not exposed to said substance and said at least one further representation is obtained during and/or after exposure of said heart to said substance.
14. The method according to claim 13 , wherein said first and further representations are obtained through continuous measurements.
15. The method according to claim 13 , whereby said substance is at least one medicine intended to treat heart disease.
16. The method according to claim 13 wherein said substance is at least one medicine to be tested for side effects on the heart muscle.
17. The method according to claim 13 whereby different areas of a heart muscle are analyzed for effects of said substance.
18. The method according to claim 13 , further comprising providing consecutive representations of the movement of electrical activity through said heart muscle.
19. The method according to claim 18 whereby said representations are obtained by continuous measurements.
20. The method according to claim 13 , further comprising comparing at least one representation of the movement of electrical activity through a heart muscle with at least one reference representation from a database.
21. The method according to claim 13 , whereby speed of activation through the heart muscle is estimated based upon the estimated activation and the estimated fiber orientation.
22. The method according to claim 13 , wherein the initial estimate of activation includes a multi-foci search for identifying an activation sequence.